Soft tissue repair Market Forecast 2017-2025 | Industry Share, Latest Trends, Investment, Top Players, Growth and Regions Forecast
According to a new report
published by KD Market Insights, titled, Soft Tissue Repair Market by
Type and Application: Global Opportunity Analysis and Industry Forecast,
2017-2025," the global soft tissue repair market was valued at $16,554
million in 2017, and is projected to reach $25,635 million by 2025, growing at
a CAGR of 5.6% from 2018 to 2025. The fixation devices segment
accounted for one-fifth share of the global market revenue in 2017.
Soft tissue injuries are
trauma caused to muscles, ligaments, and tendons. Tendons are fibrous
connective tissues that attach muscles to a bone. The damage caused by
overstressing of muscles or tendons is known as strain. Whereas, ligaments are
fibrous bands that connect bones to other bones. The injury caused due to
overstretching or tearing of ligaments is called as sprain.
Request for
Sample: https://www.kdmarketinsights.com/sample/4206
Factors that drive the
soft tissue repair market are surge in obese population and increase in
geriatric population. However, the high cost associated with soft tissue
repairs and lack of reimbursement are the factors projected to restrain the
market growth. Moreover, the untapped potential of soft tissue repairs in developing
countries, such as India, China, and Brazil, is anticipated to create lucrative
opportunities for the key market players.
Based on type, the
laparoscopic instrument segment accounted for about three-sevenths share of the
global market in 2016 owing to the increase in minimally invasive surgeries and
laparoscopic procedures globally.
By application, the hernia
repair segment accounted for the highest share in the global market owing to
the rise in hernia cases. For instance, at least 2% of men suffer from hernia
in the U.S., i.e., 15 individuals per 1000 population suffer from various forms
of hernia.
Key Findings of the
Soft Tissue Repair Market:
- The tissue mesh segment
accounted for three-eighths revenue share of the total market in 2017, and is expected
to register a CAGR of 5.8% during the forecast period.
- Biological mesh segment accounted for about half share of the global market in 2017 and is expected to garner a high CAGR of 6.0% during the forecast period.
- Dental repair segment is expected to grow at a higher CAGR of 6.4% during the forecast period.
- U.S. dominated the North America soft tissue repair market and is projected to retain its trend throughout the forecast period.
- China is expected to exhibit highest growth in the Asia-Pacific soft tissue repair market, registering a CAGR of 12.6% during the forecast period.
- Saudi Arabia is expected to exhibit highest growth in the LAMEA soft tissue repair market, registering a CAGR of 9.8% during the forecast period.
- Biological mesh segment accounted for about half share of the global market in 2017 and is expected to garner a high CAGR of 6.0% during the forecast period.
- Dental repair segment is expected to grow at a higher CAGR of 6.4% during the forecast period.
- U.S. dominated the North America soft tissue repair market and is projected to retain its trend throughout the forecast period.
- China is expected to exhibit highest growth in the Asia-Pacific soft tissue repair market, registering a CAGR of 12.6% during the forecast period.
- Saudi Arabia is expected to exhibit highest growth in the LAMEA soft tissue repair market, registering a CAGR of 9.8% during the forecast period.
Browse Full Report
& TOC: https://www.kdmarketinsights.com/product/soft-tissue-repair-market-amr
In 2017, North America was
the highest contributor to the market in terms of revenue, owing to the
increase in the wellness trend and the early adoption of novel technologies in
this sector. However, Asia-Pacific is expected to witness the highest CAGR
during the forecast period, owing to the presence of high-populace countries,
such as India and China.
The key players operating
in the global soft tissue repair market are Allergan Plc. (LifeCell
Corporation), Athersys, Inc., CryoLife, Inc., Integra Lifesciences Corporation,
Medtronic Plc., Organogenesis Inc., Stryker Corporation, Zimmer Biomet Holdings,
Inc., Smith & Nephew plc., and Becton, Dickinson and Company (C.R. Bard).
The other players operating in the value chain are Lifenet Health, Inc.,
American Medical Systems Inc., U.S. Stem Cell, Inc. (Bioheart, Inc.), Wright
Medical Group, Inc., Isto Biologics (Isto Biologics Medical Systems, Inc.).
Get Exclusive Discount
on This Report: https://www.kdmarketinsights.com/discount/4206
About Us:
KD Market Insights offers a comprehensive database of syndicated
research studies, customized reports, and consulting services. These reports
are created to help in making smart, instant and crucial decisions based on
extensive and in-depth quantitative information, supported by extensive
analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (516) 300-1215
Comments
Post a Comment